Daratumumab-Based Therapy for IgM Multiple Myeloma With Hyperviscosity Syndrome: A Case Report

Authors :: Roberto Mina
Francesca Bonello
Francesca Gay
Elena Zamagni
Mario Boccadoro
Mina R.
Bonello F.
Gay F.
Zamagni E.
Boccadoro M.
Source :: Clinical Lymphoma Myeloma and Leukemia. 21:e21-e24
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.
Abstract: NA

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
IgM
business.industry
medicine.medical_treatment
Hyperviscosity syndrome
Daratumumab
Plasmapheresis
Hematology
medicine.disease
Multiple myeloma
Internal medicine
Medicine
business

Full Text Access

Tools